"Designing Growth Strategies is in our DNA"

Insulin Pump Market Size, Share & Industry Analysis, By Product Type (Pumps [Tethered Pumps, Patch Pumps, and Others] and Consumables), By Disease Indication (Type 1 Diabetes and Type 2 Diabetes), By Distribution Channel (Hospital Pharmacy and Retail & Online Pharmacy), and Regional Forecast, 2026-2034

Last Updated: March 09, 2026 | Format: PDF | Report ID: FBI102735

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2021-2034

Base Year

2025

Estimated Year

2026

Forecast Period

2026-2034

Historical Period

2021-2024

Growth Rate

CAGR of 13.41% from 2026-2034

Unit

Value (USD billion)

Segmentation

By Product Type

  • Pumps
    • Tethered Pumps
    • Patch Pumps
    • Others
  • Consumables  

By Disease Indication

  • Type 1 Diabetes
  • Type 2 Diabetes

By Distribution Channel

  • Hospital Pharmacy
  • Retail & Online Pharmacy

By Geography

  • North America (By Product Type, By Disease Indication, By Distribution Channel, and By Country)
    • U.S. (By Disease Indication)
    • Canada (By Disease Indication)
  • Europe (By Product Type, By Disease Indication, By Distribution Channel, and By Country)
    • U.K. (By Disease Indication)
    • Germany (By Disease Indication)
    • France (By Disease Indication)
    • Italy (By Disease Indication)
    • Spain (By Disease Indication)
    • Scandinavia (By Disease Indication)
    • Rest of Europe (By Disease Indication)
  • Asia Pacific (By Product Type, By Disease Indication, By Distribution Channel, and By Country)
    • China (By Disease Indication)
    • Japan (By Disease Indication)
    • India (By Disease Indication)
    • Australia (By Disease Indication)
    • Southeast Asia (By Disease Indication)
    • Rest of Asia Pacific (By Disease Indication)
  • Latin America (By Product Type, By Disease Indication, By Distribution Channel, and By Country)
    • Brazil (By Disease Indication)
    • Mexico (By Disease Indication)
    • Rest of Latin America (By Disease Indication)
  • Middle East & Africa (By Product Type, By Disease Indication, By Distribution Channel, and By Country)
    • GCC (By Disease Indication)
    • South Africa (By Disease Indication)
    • Rest of MEA (By Disease Indication)
  • 2021-2034
  • 2025
  • 2021-2025
  • 181
Download Free Sample

    man icon
    Mail icon

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann